3vm1001
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 6, 2017 (NCT03421613)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- 3vm1001
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03142178 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2017 | CDA Research Group, Inc. |
| NCT03421613 | Early Phase 1 (Phase 1) | Mar 6, 2017 | CDA Research Group, Inc. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CDA Research Group, Inc. | For profit | 2 | 2 | 2 | 2017 |
1 organizations
Page 1 / 1